April 5th sees the start of the American Association for Neurological Surgeons (AANS) meeting being held April 5-9 in San Francisco. Zimmer Spine, Inc., has chosen the occasion to announce the U.S. market launch of a comprehensive family of Puros Demineralized Bone Matrix (DBM) with Reverse Phase Medium (RPM) Putty, Putty with Chips, Gel and Paste, and Puros DBM Block and Strip products – bone graft substitutes used to stimulate natural bone formation processes in spine surgical procedures.
Puros DBM with RPM products are unique bone graft substitutes composed of demineralized bone matrix in a reverse phase medium. Puros DBM with RPM products are designed to stimulate natural bone formation processes, in which mesenchymal cells differentiate into bone-forming cells. Puros DBM with RPM products contain a unique reverse phase medium, allowing the allograft to be malleable at operating room temperatures, while causing the product to stiffen when placed in the operating site. This property helps contains the DBM at the surgical site with minimal loss through irrigation and suction.
Puros DBM Block and Strip are unique bone graft substitutes composed of 100% demineralized cancellous bone. These allografts are ideal natural scaffolds for new bone growth because they are processed to retain osteoinductive properties by preserving endogenous growth factors including BMP2, BMP4 and BMP7 to help support new bone formation. These allografts are used during surgical procedures to help promote bone growth and joint stability. Puros DBM Block and Strip are flexible and compressible once rehydrated, and are available in a variety of sizes and shapes to reduce transplant preparation time.
Zimmer’s new range of substitutes and fillers is provided in collaboration with AlloSource (Centennial, CO).
“We have had tremendous interest in these products leading up to the launch,” said Steve Healy, President of Zimmer Spine. “Adding these six new lines to our portfolio will provide surgeons with a competitive, off-the-shelf, and convenient allograft at a good value to the hospital.”
Source: Zimmer Spine Inc., PR Newswire